Patrick R. O'Neil, EVP CLO & General Counsel at IONIS PHARMACEUTICALS INC (IONS), sold 21,000 shares at $64.56 ($1.4M) on 2025-09-09, disclosed to the SEC on 2025-09-11.
Scheduled sale ($1.4M) by EVP CLO & General Counsel under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $64.56 | 1,000 | $65K | 4.8% |
| 2 | $64.56 | 20,000 | $1.3M | 95.2% |
| Total | $64.56 avg | 21,000 | $1.4M | 100% |
| Filing → |
| IONS | SELL | 2026-02-02 | $516K | — | Filing → |
| IONS | SELL | 2026-01-20 | $697K | — | Filing → |
| IONS | SELL | 2025-10-08 | $1.2M | — | Filing → |